News • R-One robotic platform
First robotic coronary angioplasties in humans
Robocath announces the success of its first two coronary angioplasties performed with assistance from its R-One robotic platform.
News • Vascular surgery
New lease of life thanks to new aorta
Patients with the rare Loeys-Dietz syndrome suffer from aortic enlargement which may result in sudden over-expansion and a fatal aortic tear. In order to prevent this from happening, an aortic prosthesis must be implanted. A team of vascular surgeons at the University Hospital of Zurich was one of the first in the world to risk undertaking this life-saving operation on a child as an emergency…
Article • Imaging
Photoacoustic technology could 'revolutionize' cancer surgery
Cancer treatment could be dramatically improved by an invention at the University of Waterloo to precisely locate the edges of tumors during surgery to remove them.
News • Hypothyroidism
Underactive thyroid: Study validates treatment guidelines
A study led by the University of Birmingham provides strong support for current recommendations on treating patients with an underactive thyroid and validates latest UK and US guidelines, say researchers. The retrospective cohort study, published in The BMJ, analysed anonymous GP records of over 162,000 patients who have been diagnosed with hypothyroidism – a highly prevalent condition more…
News • Rare lung disease
FDA approval for scleroderma treatment
The U.S. Food and Drug Administration approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or scleroderma, called SSc-ILD. It is the first FDA-approved treatment for this rare lung condition. “Patients suffering from scleroderma need effective therapies, and the FDA supports the efforts…
News • Reopening blood vessels
Microbubbles and ultrasound can help treat heart attacks
Doctors are using microbubbles and ultrasound to treat heart attacks – deploying these traditional diagnostic tools in an attempt to reopen tiny blood vessels, reduce scar size and restore heart function, according to a study described at a medical conference in Chicago. “This study shows for the first time that microbubbles can be used to both diagnose and treat small vessel obstructions…
News • Wireless spirometer & smartphone
'Asthma app' to improve self-monitoring
A study by researchers at Karolinska Institutet shows that a treatment adjustment algorithm based on lung function and symptoms in a mobile phone can be an efficient tool in managing uncontrolled asthma. For fuss-free measuring of lung function, the phone connects to a wireless spirometer and the app can register respiratory symptoms and provide visual feedback on treatment. The study is…
Article • Cardiac regeneration potential
Cell combination heals damaged hearts
Researchers have discovered a unique combination of cells grown from stem cells that could prove pivotal in helping a heart regenerate after a patient has suffered a myocardial infarction. The University of Cambridge research team found that transplanting an area of damaged tissue with a combination of heart muscle cells and supportive cells, similar to those that cover the outside of the heart,…
Article • After myocardial infarction
Patching up a damaged heart
Scientists in the UK have developed tiny patches of engineered heart tissue that have the potential to be implanted to help people recover from a heart attack. Measuring approximately 3cm x 2cm, the patches contain up to 50 million human-induced pluripotent stem cell derived cardiomyocytes (hiPSC-CM). Yet, these are programmed to turn into working heart muscle that can beat and gradually be…
News • Quality assurance
Supporting blood donor service in Lebanon
Greiner Bio-One has been a project partner of the Swiss Red Cross since May 2019. Due to its extensive and long-term experience, SRK is in a strong position to provide support to several countries in establishing a professional blood donor service. One of these countries is Lebanon. In addition to promoting quality assurance in the blood donor service, the goal of the Swiss Red Cross is to…
Article • Risk stratification
Cardio-controversy: Added value through CAD imaging?
ESC Congress, Paris: Two key strands in the ‘Controversies in imaging coronary artery disease’ session at the congress will examine the pros and cons of imaging use for coronary artery disease risk stratification in asymptomatic patients; the second strand will focus on whether CT angiography should be the first choice for imaging coronary artery disease in patients with stable chest pain.…
Article • Highlights from the 30th TCT Meeting
Advancing transcatheter cardiovascular therapies
A remarkable number of studies and innovations were presented at the 30th anniversary of Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Diego, California. TCT 2019 will take place in San Francisco, CA between 25-29-Sep-2019. On the clinical side, the long-expected results from COAPT trial studying MitraClip device in patients with secondary mitral regurgitation and heart failure…
Sponsored • Pioneering cardiology
Implantable cardiac monitor gets diagnosis in just three days
It started as a fairly typical case: The 79-year-old patient had suffered unexplained dizziness for years. To diagnose why, the cardiology team at Sweden’s Kalmar Hospital performed echocardiograms, Holter ECGs and other tests. However, these tests showed normal sinus rhythm and thus were inconclusive. Dr Hendrik Schreyer, Dr David Olsson and Professor Jörg Carlsson decided to use…
Article • The MR-INFORM trial
Seeking a first-line ischaemia test
Findings from a comparative outcome study have highlighted the benefits of using cardiovascular magnetic resonance imaging (CMR) perfusion imaging as a first-line ischaemia test in patients with moderate risk of coronary artery disease (CAD). The MR-INFORM (Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease) trial, which began in 2012 (results published in the New England…
Article • PRIMAGE project
Aiming AI at lethal paediatric tumours
La Fe University and Polytechnic Hospital in Valencia, Spain, is coordinating EU-funded program PRIMAGE, which uses precision information from medical imaging to advance knowledge of the most lethal paediatric tumours, by establishing their prognosis and expected treatment response using radiomics, imaging biomarkers and artificial intelligence (AI).
Article • Measles
Vaccine hesitancy threatens global health
Globally, a trend of falling public trust in vaccines is alarming health officials and the World Health Organisation (WHO) lists vaccine hesitancy as one of the top 10 threats to global health. The UK’s Wellcome Trust 2018 Global Monitor – a survey of more than 140,000 people in over 140 countries – highlighted regions where confidence in vaccinations is lowest.
Article • Wishlist
Cancer prevention scrutinised
The latest study by the German Society for Haematology and Oncology (DGHO), ‘Prognosis for population-based morbidity for common cancers in Germany – impact on provision’ has made it clear that due to demographic developments in Germany and to medical advances in oncology, the requirements for cancer patients’ care are ever more diverse. The increase in newly diagnosed cancer patients is…
News • Interventional radiology
Safe, cheap embolisation for emerging countries
Vincent Vidal (Marseille, France) and colleagues have demonstrated the in vivo feasibility of arterial embolization with permanent and absorbable suture fragments, leading them to propose what they have termed the “FAIR-Embo” concept to the wider interventional radiology (IR) community. Writing in Cardiovascular and Interventional Radiology (CVIR), they conclude: “Embolization by absorbable…
News • Stem cell regeneration
Drug accelerates recovery after chemo, radiation
A drug developed by US physician-scientists and chemists speeds up the regeneration of mouse and human blood stem cells after exposure to radiation. If the results can be replicated in humans, the compound could help people recover quicker from chemotherapy, radiation and bone marrow transplants. The study, published in Nature Communications, also sheds light on the basic biology behind blood…
Video • VR simulator "HIPS"
Hip joint implantation in virtual reality
Researchers from Chemnitz and Bremen are developing a virtual reality simulator for a particularly critical step in hip joint implantation. Each year, more than 200,000 people receive a prosthetic hip in Germany. The success of these operations has a major impact on the quality of life of those affected. However, the procedure is often difficult, particularly the step that involves the so-called…
Video • Improved motion range
Brace yourselves: Robotic neck support for ALS patients
A novel neck brace, which supports the neck during its natural motion, was designed by Columbia engineers. This is the first device shown to dramatically assist patients suffering from Amyotrophic Lateral Sclerosis (ALS) in holding their heads and actively supporting them during range of motion. This advance would result in improved quality of life for patients, not only in improving eye contact…
News • Microstents vs foetal urethral strictures
The world’s smallest stent
Researchers at ETH Zurich have developed a new method for producing malleable microstructures – for instance, vascular stents that are 40 times smaller than previously possible. In the future, such stents could be used to help to widen life-threatening constrictions of the urinary tract in foetuses in the womb. Approximately one in every thousand children develops a urethral stricture,…
News • Biocompatible alternative
Non-silicone breast implant to enter clinical trial
Surgery complications, implant rupture, tissue contractures or even plain immune intolerance – silicone breast implants can cause a variety of unfavourable conditions. Because of this, many women think twice about breast augmentation. A new kind of implant might change this up a bit. BellaSeno GmbH, a company developing absorbable implants using additive manufacturing technology, now announced…
News • Epidemiology
Tuberculosis: A quarter of the world's population at risk
A new study from Aarhus University Hospital and Aarhus University has shown that probably 1 in 4 people in the world carry the tuberculosis bacterium in the body. The disease tuberculosis is caused by the bacterium Mycobacterium Tuberculosis, which affects more than 10 million people every year, and kills up to 2 million, making it the most deadly of the infectious diseases.
News • Hidden chemistry
This flower might hold the key to killing cancer cells
Researchers at the University of Birmingham have shown that it’s possible to produce a compound with anti-cancer properties directly from feverfew – a common flowering garden plant. The team was able to extract the compound from the flowers and modify it so it could be used to kill chronic lymphocytic leukaemia (CLL) cells in the laboratory. Feverfew is grown in many UK gardens, and also…